GGrantIndex
Sort

40,608 grants matching prostate cancer

Point-of-care ultrahigh sensitivity magnetic lateral flow assay

$443,988
Dmitri Litvinov · University Of Houston · · FY2019 · ENG

Agents for Specific NMR and SQUID Imaging of Prostate Cancer

$443,966
Laurel O Sillerud · University Of New Mexico · R01 · FY2008 · CA

3-way approach for ED prevention

$443,939
Carol Ann Podlasek · University Of Illinois At Chicago · R01 · FY2016 · DK

B7-H1/PD-1 modulation in cancer therapy

$443,937
Drew M. Pardoll · Johns Hopkins University · R01 · FY2014 · CA

Progenitor cells of the mouse prostate epithelium

$443,934
Michael M. Shen · Columbia University Health Sciences · R01 · FY2013 · DK

NOVEL PROSTATE CANCER GENE AND MONOCLONAL ANTIBODY

$443,844
Columbia University Health Sciences · R01 · FY2000 · CA

Biomarker Reference Laboratory, EDRN

$443,807
William E. Grizzle · University Of Alabama At Birmingham · U24 · FY2008 · CA

Cancer in adults following in utero and early life exposure to arsenic

$443,807
Craig M Steinmaus · University Of California Berkeley · R01 · FY2017 · ES

PheWAS and GWAS of Telomere Length to Understand Human Disease

$443,796
Scott Joseph Hebbring · Marshfield Clinic Research Foundation · R01 · FY2023 · GM

Efficacy and Mechanisms of Resistance to Neoadjuvant Intensive Androgen Signaling Inhibition

$443,790
Mary E Taplin · Dana-Farber Cancer Inst · P50 · FY2024 · CA

Computer Support for Prostate Cancer Screening in the PLCO Cancer Screening Trial

$443,776
William Lake · Information Management Services, Inc. · N02 · FY2011 · CA

G-protein-coupled receptor signaling in cancer development and treatment

$443,768
Ramiro Iglesias-Bartolome · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

KanSurvive: Testing a model for improving cancer survivorship care in rural practice

$443,740
Jennifer Rose Klemp · University Of Kansas Medical Center · R01 · FY2022 · CA

BKV and JCV vaccine development

$443,703
Christopher Buck · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

5 ALPHA REDUCTASE GENOTYPE, RACE PROSTATE CANCER RISK

$443,701
University Of Southern California · R01 · FY2002 · CA

Gaining Metabolic Insight in Older Men undergoing Androgen Deprivation Therapy for Prostate Cancer

$443,641
Shehzad Basaria · Brigham And Women'S Hospital · R01 · FY2019 · CA

Cancer in adults following in utero and early life exposure to arsenic

$443,622
Craig M Steinmaus · University Of California Berkeley · R01 · FY2016 · ES

Enhanced imaging and treatment of aggressive subtypes of prostate cancer

$443,607
Martin G Pomper · Johns Hopkins University · R01 · FY2022 · CA

Novel L-threo-sphinganines for ceramides-based cancer therapy

$443,579
Barry J Maurer · Texas Tech University Health Scis Center · R15 · FY2012 · CA

CLINICAL AND EPIDEMIOLOGICAL CENTER--PROSTATE CANCER

$443,574
Johns Hopkins University · U01 · FY2002 · CA

Engineering diverse commensal skin bacteria for targeted immunotherapy

$443,564
Yiyin Erin Chen · Broad Institute, Inc. · R21 · FY2025 · CA

Improving prostate biopsy efficiency: The finasteride challenge test

$443,502
Javier Hernandez · University Of Texas Hlth Science Center · R01 · FY2012 · CA

Pattern recognition in medical imaging

$443,483
Ilya Goldberg · National Institute On Aging · ZIC · FY2010 · AG

Clinical Fellowship Training Program

$443,471
Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2017 · CA

Prostate Section

$443,471
Peter Pinto · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA